美國生物醫療藥品市場：2009-2013年 是由出版商Infiniti Research Limited在2010年08月所出版的。
這份英文市場調查報告書包含Pages: 18 價格從美金1500起跳。
Abstract
Biotechnology Pharmaceutical Market in US 2009-2013 report by Technavio
Insights forecasts the Biotechnology Pharmaceutical market to grow at a CAGR
of 7.7 percent, with Blood Modifiers accounting for the largest share of the
market at 36.3 percent.
The major growth drivers include:
- Increasing demand for biotechnology
drugs with enhanced efficiency, safety and popularity
- Revision of
regulations and standards in favour of biotechnology drugs are encouraging
more companies to invest in the field
- Increasing ageing population and
the prevalence of chronic and age related illnesses is also driving the demand
for biotechnology pharmaceuticals
However, the market is faced with some challenges which can inhibit the
growth, such as the increasing healthcare expenditure in the US. Many
biotechnology pharmaceutical companies are facing cost containment pressure.
Lack of technical development and expertise is an issue as these companies
need to employ highly skilled medical professionals.
For the purpose of this report, the Biotechnology Pharmaceutical market refers
to drugs, medicines or vaccines developed through biotechnology such as
recombinant DNA technology, combinatorial chemistry, gene therapy, and
monoclonal antibodies. The report analyzes Biotechnology Pharmaceutical
market’s recent performance and provides the US market revenue and
growth rates from 2009 through to 2013. It also provides detailed market
segmentation based on the type of disease the drugs are formulated to treat
or based on therapeutic class. The report includes comprehensive analysis of
various trends and changes taking place in the Biotechnology Pharmaceutical
market in the US.
It also explains the factors influencing market growth and also inhibitors
preventing their adoption. The report provides basic profiles of some of the
leading vendors in the market
Table of Contents
1. Introduction
2. Market Size and Forecast
3. Market Segmentation
4. Market Trends in Biotechnology Pharmaceutical in US
5. Market
Drivers in Biotechnology Pharmaceutical in US
6. Market Challenges in
Biotechnology Pharmaceutical in US
7. Vendors
8. Related Reports in
this Series
List of Exhibits
Exhibit 2.1:
Biotechnology Pharmaceutical in US Market Size and Forecast 2009-2013 (In
$billion)
Exhibit 3.1: US Biotechnology Pharmaceutical Market
Segmentation -2009
